Are you interested in learning about how the safety of COVID‑19 vaccines is being monitored?
If so, you might like to attend the 6th Pharmacoepidemiology Research Network Symposium.
Several speakers will discuss the COVID‑19 vaccine safety monitoring that is being undertaken both internationally and in New Zealand:
- Ms Julianne Gee, an epidemiologist from the United States Centers for Disease Control and Prevention who is currently serving as the Deputy Team Lead of the Vaccine Safety Team on the CDC’s COVID‑19 Vaccine Task Force and as a senior technical advisor to the Global Immunization Safety Team.
- Professor Michael Gold, a paediatric allergist and immunologist who has contributed to several World Health Organization vaccine safety guidelines and is a committee member of the Vaccine Safety Investigation Group (VSIG) of the Australian Therapeutic Goods Administration and of the AusVaxSafety Expert Advisory Group for Active Vaccine Surveillance.
- Associate Professor Helen Petousis-Harris, a vaccinologist who previously chaired the World Health Organization’s Global Advisory Committee on Vaccine Safety (GACVS) and is currently an elected member of the Brighton Collaboration Science Board.
Medsafe representatives will discuss the COVID‑19 vaccine safety monitoring that is being undertaken in New Zealand.
|Date||Tuesday, 23 November 2021|
|Time||10:00am - 4:30pm|
|Audience||Postgraduate students,Staff,Allied health professionals|
|Event Category||Health Sciences|
|Contact Name||Lianne Parkin|
|Contact Phone||+64 3 479 8425|